https://prokidney.com/

https://prokidney.com/our-technology/react-platform/

Renal Autologous Cell Therapy: REACT™

Early clinical data suggest REACT may stop the progression of CKD, and may promote meaningful improvement in kidney function.

Autologous cell therapy refers to the prevention or treatment of human disease by the administration of a person’s own cells that have been multiplied, selected and formulated for delivery outside the body. We believe that our technology has the potential to restore kidney function by using a patient’s own selected renal cells (SRCs).